To follow up My figure dealt with the highest that they attained in the two years time period. I was looking at sales vs rev. in 2018 when abbv hit $3.6bil in sales enta's commission started at 4.78% and progressed to 5.8%, 7.7% and ended at 8.10% in the 4th q. If Sales this year end up at the $2.0 billion range you'll get stuck at the 6% range